Objective: Previous small studies have found a high occurrence of bloodstream infections (BSIs) in patients with intestinal failure, and these rates are higher than reported rates in other pediatric populations with central lines. The primary study objective was to describe the occurrence of BSIs in patients with intestinal failure who present to the pediatric emergency department (ED) with fever. Conclusions: Pediatric patients with intestinal failure and central lines have a high occurrence of BSIs with 69% of cultures positive in this study of ED febrile episodes. In contrast to reports in other populations with central lines, BSI occurrence in patients with intestinal failure and fever is higher and larger proportions are gram-negative and enteric organisms. For these patients, we recommend central and peripheral blood cultures, empiric broad spectrum antibiotics targeting gram-negative and enteric organisms, and hospital admission.
I
ntestinal failure is defined as a condition whereby either an extensive surgical bowel resection or a medical condition results in inadequate intestinal function to maintain fluid, electrolytes, or the nutrition needed for growth. 1, 2 The classic form of intestinal failure is "short gut" syndrome, in which the intestine is too short as a consequence of surgical resection. 3, 4 The incidence of short gut syndrome is estimated to be 5 to 25/100,000 births per year and up to 700 per 100,000 in very low birth weight infants (<1500 g). [4] [5] [6] [7] However, the overall incidence of intestinal failure is unknown.
Patients with intestinal failure require total parenteral nutrition administered via a central line. Unique to patients with indwelling central lines, patients with intestinal failure are believed to be at particularly high risk for bloodstream infections (BSIs). This is thought to be due to several reasons including possible bacterial colonization of the total parenteral nutrition, contamination of the central line from high stool output, and the theoretical risk of bacterial translocation at the level of the gut, which has been described in multiple animal models. 8, 9 Although the rate of bacteremia has been shown to be approximately 20% in febrile pediatric oncology patients, data on the occurrence of bacteremia among pediatric patients with intestinal failure who present with fever are limited. [10] [11] [12] In addition to potentially higher rates of bacteremia, the pathogens for BSIs in intestinal failure patients seem to differ from other populations with central lines. Although gram-positive infections predominate in other populations, a few small studies of patients with intestinal failure have described BSIs with gram-negative and enteric pathogens at rates of 35% to 44% and 59%, respectively. [12] [13] [14] [15] Given the potential higher risk for BSIs and limited small previous studies, we sought to further investigate the occurrence of bacteremia in pediatric patients with intestinal failure and fever presenting to the emergency department (ED). The primary objective of this study was to describe the occurrence of BSIs in pediatric intestinal failure patients with a central line who present to the ED with fever. The secondary objectives were to describe the pathogens and clinical aspects of BSIs in this population.
METHODS

Study Population and Design
A retrospective chart review of febrile patients with intestinal failure who presented to the ED at Children's Hospital of Pittsburgh was conducted between July 1, 2006, and June 30, 2011. We identified subjects using a database of patients with intestinal failure from the Division of Gastroenterology at our institution. Because many of these patients are potential candidates for bowel transplantation, we also cross-referenced the intestinal failure database against a list of prebowel and postbowel transplantation patients from the Department of Transplant Surgery. Medical records of patients with intestinal failure were reviewed to identify all eligible ED visits for febrile episodes. Emergency department febrile episodes were included if patients were younger than 20 years, had a central line, and a fever of 38.0°C or greater either at home, in the ED, or at a transferring facility. If a patient underwent organ transplantation during the study, subsequent ED visits for fever posttransplantation were excluded.
A single investigator (E.G.S.) reviewed all medical records that included transfer, ED, and inpatient records. A standardized form developed for this study was used to record all data, which included demographics, vital signs, blood culture results, antibiotics administered, and disposition. Disposition from the ED was categorized as discharged home from the ED, admitted to the general inpatient unit, admitted directly to the pediatric intensive care unit (PICU), or initially admitted to the general inpatient unit and transferred to the PICU within 24 hours.
All blood cultures drawn in our institution's ED were included. The protocol at our institution is to obtain central and peripheral blood cultures for patients with intestinal failure and central lines who present to the ED with fever of 38.0°C or higher. Blood cultures from transferring institutions were included if there was documentation of the results in the medical records. As is standard in the care of patients with intestinal failure, central blood cultures were defined as BSIs when any organism was cultured from blood obtained from a central line during a febrile illness. 12 Urine cultures, if obtained, were recorded and were defined as positive if there were greater than 50,000 CFU of a single organism.
Statistical Analysis
Each febrile episode was analyzed independently at the visit level. We chose to analyze at the visit level instead of reporting a subanalysis at the patient level because we felt data describing febrile episodes instead of individual patients would be more practical and valuable for the clinician evaluating patients with intestinal failure and fever in the ED. Descriptive statistics were used for demographics and clinical characteristics. χ 2 test was used for the evaluation of categorical variables. Mann-Whitney U test was used for comparison of nonparametric data. Statistical significance was defined as a P value of less than 0.05. Study data were collected and managed using REDCap electronic data capture tools hosted at the University of Pittsburgh. 16 Statistical analyses were conducted using Statistical Program for the Social Sciences, Version 19.1.1 (SPSS). This study was approved by the University of Pittsburgh Institutional Review Board.
RESULTS
Subject Characteristics
There were 422 patients identified from the combined Gastroenterology and Transplant Surgery registries. Of these 422 patients, 72 patients met study criteria and had a total of 519 febrile ED episodes during the 5-year study period (Fig. 1 ). The mean (SD) number of febrile ED episodes for the 72 study patients included was 7.2 (6.8; range, 1-33).
The median (interquartile range [IQR]) age for patients presenting with febrile episodes was 21(13-38) months and 52% of patients were male. The most common underlying etiologies of intestinal failure at both the patient level and the visit level were necrotizing enterocolitis and gastroschisis ( Table 1 ). The small number of patients with each underlying diagnosis, however, limits the ability to determine whether any one etiology confers an increased risk for BSI. Most episodes (97%) involved patients with tunneled central lines and 3% of episodes were in patients with peripherally inserted central catheters. Home use of ethanol locks before the ED visit was reported in 18 of the 519 episodes, and home antibiotic locks were not recorded. Of note, 8% (42/519) of patients in this study were initially evaluated at other institutions and were transferred to our pediatric ED for further evaluation and 37 of 42 had blood cultures drawn before transfer.
Occurrence of BSI
Central blood cultures were obtained in 93% (480/519) of febrile ED episodes and 69% (330/480) were positive for a BSI. Of all BSIs, 38% (124/330) were polymicrobial, 32% (105/330) were a single gram-positive organism, 25% (84/330) were a single gram-negative organism, and 5% (17/330) were a single fungal organism. In total, 501 pathogens were isolated from the 330 positive central cultures. Pathogen types are listed in Table 2 . Of the bacterial pathogens, 52% (237/460) were gram-positive and 48% (223/460) were gram-negative. Overall, 60% of pathogens were enteric organisms. All fungal organisms were Candidal species and accounted in total for 8% (41/501) of all isolates.
To determine whether there is line colonization without spread to the periphery, our institution recommends obtaining both central and peripheral blood cultures when possible, as part of the initial evaluation of patients with intestinal failure and fever. Central cultures were obtained in 93% (480/519) of febrile episodes, peripheral cultures were obtained in 64% (330/519), and both central and peripheral cultures were obtained in 58% (330/ 519, Table 3 ). When both a central and peripheral culture were obtained (303 febrile episodes), the peripheral culture was negative in 26% (80/303) of episodes. When both a central and peripheral culture were obtained and were both positive, at least one of the same organism was isolated in 97% (129/133) of episodes. Of note in these cases, coagulase-negative Staphylococcus was isolated in 38 central cultures, and of these, 33 had peripheral cultures that also isolated coagulase-negative Staphylococcus.
There were 3 febrile episodes in which the peripheral culture was positive and the central culture was negative, and in all cases, the patients were admitted and treated with intravenous antibiotics. In these cases, the peripheral cultures were positive for diptheroids, coagulase-negative Staphylococcus, and Bacillus nonanthracis, respectively, and were considered contaminants by the clinicians.
The rate of bacteremia was similar between the patients with a tunneled catheter (321/465, 69%) and peripherally inserted central catheter (9/15, 60%; P = 0.57). 
Urinary Tract Infections
Urine cultures were performed in 37% (194/519) of febrile episodes and 9% (18/194) were positive. The mean (SD) age of patients with urinary tract infections was 23.8(19.6) months and 22% were male. The most common urinary organism cultured was Escherichia coli (11/18). A concurrent central blood culture with the same organisms consistent with urosepsis was found in 44% (8/18) of episodes (2 Klebsiella pneumonia, 2 E. coli, 2 Enterococcus faecalis, 1 Proteus species, and 1 methicillin-sensitive Staphylococcus aureus). Both central and peripheral cultures were positive for the same urinary organism in 28% (5/18) of urinary tract infections.
Antibiotics
Antibiotics were administered in the ED in 94% (489/519) of febrile episodes. Excluding those transferred from outlying facilities, the median (IQR) time from triage to administration of the first dose of antibiotics was 2.3(1.7-3.1)hours. There was no significant difference between median time to antibiotics and ED disposition. The most common antibiotics administered were vancomycin (382/489, 78%) and piperacillin/tazobactam (378/489, 77%). The combination of vancomycin and piperacillin/tazobactam was given in 61% (296/489) of febrile episodes. Antifungal agents were administered in the ED in 5% (26/489) of febrile episodes.
Bloodstream Infection Occurrence and ED Disposition
Most patients were admitted to the hospital; 85% (443/519) were admitted to the general inpatient unit, 9% (44/519) were admitted directly to the PICU, 2% (12/519) were admitted to inpatient unit and transferred to the PICU within 24 hours because of septic shock, and 4% (20/519) were discharged home from the ED. Of the 20 patients discharged home from the ED, 6 (30%) returned to the ED within 48 hours and were admitted to the inpatient unit, 2 returned after report of positive blood cultures, 2 returned with persistent fevers, 1 had persistent fatigue, and 1 had 
DISCUSSION
In this study, we found that 69% of central blood cultures were positive for BSI in patients with intestinal failure and central lines presenting to a single pediatric ED with fever. To our knowledge, these data represent the largest study of BSIs in febrile pediatric intestinal failure patients presenting to an ED. The results support previous smaller studies indicating the occurrence of bacteremia in febrile patients with intestinal failure, and central lines is higher than in other populations with fever and central lines, which have reported occurrences of 6% to 23%. 4, 8, 10, [17] [18] [19] [20] [21] [22] [23] [24] Although it is possible that some of the central blood culture results were contaminants, the extremely high degree of overlap in isolates when both a central and peripheral culture were obtained during a febrile illness suggests that these are real pathogens. Our data support that all patients with fever and central lines should not be treated the same given the propensity for positive cultures in the pediatric intestinal failure population. Although other populations with central line and fever evaluated in the ED setting, such as oncology patients, may be risk stratified into high versus low risk for infection and possible candidates for outpatient management, our pediatric intestinal failure population patients should be admitted to the hospital and treated with antibiotics pending culture results. 25, 26 In addition to the high occurrence of BSIs, we also found that organisms differ from other populations with central lines with a high rate of gram-negative and enteric organisms, consistent with smaller studies. [12] [13] [14] Previous research in pediatric patients with cancer has shown that 20% to 30% of BSIs are caused by gramnegative organisms versus our study population in which 48% of the pathogens were gram-negative. 23, 27 Interestingly, we found that 60% of BSIs were caused by enteric organisms. This may support the theory of gut translocation or may represent the organisms that colonize the skin of these patients. Furthermore, it suggests that typical empiric antibiotic approaches for BSIs in patients with central lines, such as vancomycin and a third-or fourth-generation cephalosporin may not be appropriate for patients with intestinal failure. We recommend initiating antibiotics that cover grampositive, gram-negative, and enteric organisms, such as vancomycin and piperacillin/tazobactam, in patients with intestinal failure and fever.
Peripheral blood cultures are used by our institution to guide treatment options. A negative peripheral culture with a positive central culture suggests that additional methods of eradication, such as antibiotic locks, may be useful. Our data support the recommendation to obtain peripheral cultures in these patients as we found the combination of a positive central culture with a negative peripheral culture in 26% (80/303) of BSIs in which both a peripheral and central blood culture was obtained. Due to the difficulty of replacing central lines in children, current guidelines recommend the combination of antibiotic lock therapy and systemic antibiotics for catheter salvage when possible. 15 We found the prevalence of urinary tract infection to be 9% in our population with an extremely high rate of concomitant bacteremia (44%, 8/18) . This is in contrast to healthy infants and children presenting to the ED with fever, in which the rate of urinary tract infection is 3% to 5% and the prevalence of bacteremia in those with a urinary tract infection is 4% to 9%. [28] [29] [30] [31] This is also in contrast to a recent study of febrile pediatric patients with cancer and neutropenia who had a similar rate of urinary tract infections (8.6%), yet none of these patients had concurrent bacteremia. 32 Of note, the median age of the febrile oncology patients in this study was 8 years, which is much higher than the median age in our study population (21 months) . Because urine cultures were obtained in less than half of febrile episodes in our study, further investigation is warranted to confirm this high risk of urosepsis in febrile pediatric patients with intestinal failure.
There have been several studies linking early initiation of antibiotic therapy with decreased mortality in patients with severe sepsis or septic shock. [33] [34] [35] We used PICU admission or transfer to the PICU within 24 hours as a proxy for severity of illness. Unexpectedly, our study did not find an association between documented time to antibiotics and admission to the PICU or transfer to PICU. Although we do not advocate for delayed antibiotic administration, our data would suggest that timing within 2 to 3 hours did not alter outcomes for our patients in this study.
Limitations
This was a retrospective chart review at a single center and thus includes limitations inherent to the study design. Although interrater reliability was not performed for chart review, a single reviewer and a standardized data collection form designed for this study were used to limit recording errors. Febrile episodes that were directly admitted to the inpatient unit or PICU (and bypassed the ED) were excluded, which could affect the occurrence of BSIs. However, this is uncommon at our institution and thus unlikely to alter the BSI rate significantly. We were unable to report a central line-associated blood stream infection rate per 1000 catheter days, recurrence rate, or prevalence of bacteremia because our study population was limited to those patients evaluated in the ED and not the entire intestinal failure population, some of whom may never have had a BSI and others who were evaluated solely at other institutions. However, given our study's large number of ED visits in pediatric patients with intestinal failure and fever, we believe that the data are representative of the occurrence of BSIs during acute febrile illness and generalizable to this population. Finally, this study was limited to the ED setting and, therefore, did not include infants in the neonatal intensive care unit with intestinal failure who have a much higher reported rate of mortality. 24 
CONCLUSIONS
In summary, pediatric patients with intestinal failure and central lines are a vulnerable population at high risk of BSIs with 69% of cultures positive in this study of ED febrile episodes. Contrary to reports in other populations with central lines, BSI occurrence in patients with intestinal failure and fever is higher and larger proportions are gram-negative and enteric organisms. For pediatric intestinal failure patients with central lines and fever evaluated in the ED, we recommend central and peripheral blood cultures, empiric broad spectrum antibiotics targeting gram-negative and enteric organisms, and hospital admission.
